Simcere

Simcere (2096.HK) is an innovation- and R&D-driven pharmaceutical company that has established the "National Key Laboratory for Neurology and Oncology Drug Research and Development." The company focuses on oncology, neurology, autoimmune diseases, and anti-infectives, while proactively making forward-looking investments in disease areas with significant future clinical needs. It is committed to "enabling patients to access more effective drugs sooner." Simcere operates through a dual engine of independent R&D and collaborative innovation, forming strategic partnerships with multiple innovative enterprises and research institutions.